Global Point of Care
Global Point of Care
Uno studio sui ricoveri di emergenza in Inghilterra ha rilevato che oltre un quarto dei ricoveri non ha richiesto un pernottamento (durata della degenza [LoS, Lenght of stay] pari a zero).1 Questo suggerisce che molti pazienti in stato di emergenza potrebbero trarre vantaggio dall'assistenza ambulatoriale di emergenza (AEC)1 adottando un approccio sistematico per la riprogettazione dei processi. Questo comporta l'accesso immediato alle cure urgenti che di solito richiedono le risorse e le competenze disponibili in un reparto di terapia intensiva.2
È probabile che i dispositivi POCT integrati, come i-STAT System™, offrano più opzioni per la gestione dei pazienti in un contesto di AEC.
*I risultati qui mostrati sono specifici di questa struttura sanitaria e possono differire da quelli ottenuti da altri enti.
A study of emergency admissions in England found that over a quarter of admissions did not require an overnight stay (length of stay [LoS] of zero).1 This suggests that many emergency patients could benefit from ambulatory emergency care (AEC)1 by having a systematic approach to process redesign. This entails immediate access to urgent care that would usually require the resources and expertise available in an acute hospital.2
Integrated POCT devices, such as the i-STAT System™ , are likely to offer more options for managing patients in an AEC setting.
*The results shown here are specific to this health care facility and may differ from those achieved by other institutions.
Ridurre la durata della degenza per i pazienti
Diminuzione del 60% della durata della degenza (processo di riprogettazione semestrale)
aumento dei pazienti con 0 giorni di durata della degenza
25% di ingressi in meno
Vantaggio economico
più di 1 milione di dollari all'anno
Reduce LoS for patients
60% decrease in LoS (half-year post-redesigned process)
increase in patients with 0 days LoS
25% fewer admissions
Economic benefit
more than £1 million per annum
A Leader in Rapid Point-of-Care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement (last updated: May 2018) | Declaration for California Compliance Law.
Abbott Rapid Diagnostics S.r.l. - Edison Center, Edificio C - Viale Thomas A. Edison, 110 - 20099 Sesto San Giovanni (MI).
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
